Potentiation of C-type natriuretic peptide with ultrasound and microbubbles to prevent neointimal formation after vascular injury in rats

Cardiovascular Research

Volumn 58, Issue 1, 2003, Pages 231-238

  Takeuchi, Hiroto ^a   Ohmori, Koji ^a   Kondo, Isao ^a   Oshita, Akira ^a   Shinomiya, Kaori ^a   Yu, Yang ^a   Takagi, Yuichiro ^a   Mizushige, Katsufumi ^a   Kangawa, Kenji ^b   Kohno, Masakazu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Natriuretic peptide; Receptors; Restenosis; Smooth muscle; Ultrasound

Indexed keywords

ALBUMIN; FS 069; NATRIURETIC PEPTIDE TYPE C; OCTAFLUOROPROPANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; CAROTID ARTERY INJURY; CONTROLLED STUDY; DEVICE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; DRUG POTENTIATION; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; FEASIBILITY STUDY; FIBROMUSCULAR DYSPLASIA; INTIMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; SHORT COURSE THERAPY; TUNICA MEDIA; ULTRASOUND;

ANALYSIS OF VARIANCE; ANIMALS; CAROTID ARTERY INJURIES; CAROTID STENOSIS; CATHETER ABLATION; COMBINED MODALITY THERAPY; CYCLIC GMP; MALE; NATRIURETIC PEPTIDE, C-TYPE; RATS; RATS, SPRAGUE-DAWLEY; TUNICA INTIMA; ULTRASONIC THERAPY;

EID: 0037401067     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00833-7     Document Type: Article

References (46)

1. Austin G.E., Ratliff N.B., Hollman J., Tabei S., Phillips D.F. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 6:1985;369-375.
2. Libby P., Schwartz D., Brogi H., Tanaka H., Clinton S.K. A cascade model for restenosis: A special case of atherosclerosis progression. Circulation. 86:1992;III47-III52.
3. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nature Med. 4:2002;403-409.
4. Morice M.C., Serruys P.W., Sousa J.E., et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New Engl J Med. 346:2002;1773-1780.
5. Sudoh T., Minamino N., Kangawa K., Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 168:1990;863-870.
6. Koller K.J., Lowe D.G., Bennett G.L., et al. Selective activation of B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 252:1991;120-123.
7. Ikeda M., Kohno M., Yasunari K., et al. Natriuretic peptide family as a novel antimigration factor of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;731-736.
8. Kohno M., Yokokawa K., Yasunari K., et al. Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells. Circ Res. 81:1997;585-590.
9. Hutchinson H.G., Trindade P.T., Cunanan D.B., Wu C.F., Pratt R.E. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc Res. 35:1997;158-167.
10. Furuya M., Aisaka K., Miyazaki T., et al. C-type natriuretic peptide inhibits intimal thickening after vascular injury. Biochem Biophys Res Commun. 193:1993;248-253.
11. Shinomiya M., Tashiro J., Saito Y., et al. C-type natriuretic peptide inhibits intimal thickening of rabbit carotid artery after balloon catheter injury. Biochem Biophys Res Commun. 205:1994;1051-1056.
12. Bao S., Thrall B.D., Miller D.L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol. 23:1997;953-959.
13. Anwer K., Kao G., Proctor B., et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther. 7:2000;1833-1839.
14. Shohet R.V., Chen S., Zhou Y.T., et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation. 101:2000;2554-2556.
15. Fukunaga M., Makita N., Roberts II L.J., et al. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol. 264:1993;C1619-1624.
16. Kojima M., Minamino N., Kangawa K., Matsuo H. Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP). FEBS Lett. 276:1990;209-213.
17. Tawaragi Y., Fuchimura K., Tanaka S., et al. Gene and precursor structures of human C-type natriuretic peptide. Biochem Biophys Res Commun. 175:1991;645-651.
18. Clark L.N., Dittrich H.C. Cardiac imaging using Optison. Am J Cardiol. 86:2000;14G-18G.
19. Inoue Y., Toga K., Sudo T., et al. Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model. Br J Pharmacol. 130:2000;231-241.
20. Naruko T., Ueda M., van der Wal A.C., et al. C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation. 94:1996;3103-3108.
21. Garg U.C., Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 83:1989;1774-1777.
22. Marumo T., Nakaki T., Hishikawa K., et al. Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3′,5′-monophosphate elevation in vascular smooth muscle cells. Endocrinology. 136:1995;2135-2142.
23. Stingo A.J., Clavell A.L., Aarhus L.L., Burnett J.C. Jr. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 262:1992;H308-312.
24. Morishige K., Shimokawa H., Yamawaki T., et al. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol. 35:2000;1040-1047.
25. Gabeler E.E.E., van Hillegersberg R., Statius van Eps R.G., et al. A comparison of balloon injury models of endovascular lesions in rat arteries. BMC Cardiovasc Disord. 2:2002;16.
26. Fishman J.A., Ryan G.B., Karnovsky M.J. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 32:1975;339-351.
27. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
28. Kennedy S., McPhaden A.R., Wadsworth R.M., Wainwright C.L. Correlation of leukocyte adhesiveness, adhesion molecule expression and leukocyte-induced contraction following balloon angioplasty. Br J Pharmacol. 130:2000;95-103.
29. Okamoto E., Couse T., De Leon H., et al. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation. 104:2001;2228-2235.
30. Scott N.A., Cipolla G.D., Ross C.E., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation. 93:1996;2178-2187.
31. Edelman E.R., Nugent M.A., Smith L.T., Karnovsky M.J. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 89:1992;465-473.
32. Prescott M.F., McBride C.K., Court M. Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol. 135:1989;835-846.
33. Roque M., Fallon J.T., Badimon J.J., et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 20:2000;335-342.
34. Suzuki T., Kopia G., Hayashi S., et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation. 104:2001;1188-1193.
35. Yasukawa H., Imaizumi T., Matsuoka H., Nakashima A., Morimatsu M. Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. Circulation. 95:1997;1515-1522.
36. Barron M.K., Lake R.S., Buda A.J., Tenaglia A.N. Intimal hyperplasia after balloon injury is attenuated by blocking selectins. Circulation. 96:1997;3587-3592.
37. Kumar A., Hoover J.L., Simmons C.A., Lindner V., Shebuski R.J. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation. 96:1997;4333-4342.
38. Miller A.M., McPhaden A.R., Wadsworth R.M., Wainwright C.L. Inhibition by leukocyte depletion of neointima formation after balloon angioplasty in a rabbit model of restenosis. Cardiovasc Res. 49:2001;838-850.
39. Kubo A., Isumi Y., Ishizaka Y., et al. C-type natriuretic peptide is synthesized and secreted from leukemia cell lines, peripheral blood cells, and peritoneal macrophages. Exp Hematol. 29:2001;609-615.
40. Shinomiya K., Ohmori K., Kondo I., et al. C-type natriuretic peptide limits renal ischemia/reperfusion injury by inhibiting migration of activated leukocytes [abstract]. Circ J. 66:2002;692.
41. Mukherjee D., Wong J., Griffin B., et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol. 35:2000;1678-1686.
42. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 98:1998;290-293.
43. Brandt R.R., Mattingly M.T., Clavell A.L., Barclay P.L., Burnett J.C. Jr. Neutral endopeptidase regulates C-type natriuretic peptide metabolism but does not potentiate its bioactivity in vivo. Hypertension. 30:1997;184-190.
44. Indolfi C., Esposito G., Lorenzo E.D., et al. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 92:1995;1230-1235.
45. Indolfi C., Cioppa A., Stabile E., et al. Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury. J Am Coll Cardiol. 35:2000;214-221.
46. Ohlstein E.H., Romanic A.M., Clark L.V., et al. Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery. Cardiovasc Res. 47:2000;759-768.